美國分子儀器公司（MDC）是NASDAQ上市公司，全球高品質(zhì)生物分析檢測系統(tǒng)的先導者。我們的產(chǎn)品整合了工程學、分子和細胞生物學、電生理學和化學等學科的高新技術，廣泛應用于分子生物學、免疫學、細胞學、生物化學、電生理、高通量藥物篩選和藥物開發(fā)等領域，并且在全球酶標儀市場和藥物篩選領域具有極高的口碑。公司的全球總部位于美國硅谷，在英國、德國、挪威、韓國和日本均設有分支機構(gòu)。2005年美國分子儀器公司正式進駐中國，總部設在上海。Molecular Devices Corporation(MDC)公司成立于1983年，位于美國高科技密集的加里佛尼亞州，是一家致力于為生命科學和藥物研發(fā)工作者提供專業(yè)的、高精度、高通量、高性能的微孔板測讀分析儀和液體操作系統(tǒng)的廠商，擁有該領域的上百項專利技術，系列產(chǎn)品已被廣泛應用于藥物篩選、分子生物學、免疫學、細胞學、生物化學、電生理學等多個領域，是微孔板測讀分析領域的國際第一品牌。UniversalImaging Corporation和Axon Instruments現(xiàn)已成為MDC公司的成員。 MDC系列產(chǎn)品如下： ● 細胞成像ImageXpress Micro，ImageXpress Ulltra，ImageXpress 5000A，MetaMorph ● 電生理系統(tǒng)IonWorks Quattro, PatchXpress 7000A, OpusXpress 6000A,微電極放大器，數(shù)據(jù)獲取系統(tǒng)，電穿孔儀 ● 熒光成像分析系統(tǒng) FLIPRTETRA?，F(xiàn)lexStation ● 液體處理系統(tǒng)分液器，洗板機，細胞收獲器 ● 生物芯片 Axon GenePix系列芯片掃描儀 ● 酶標儀光吸收SpectraMax系列，化學發(fā)光LMaxII384，熒光GeminiXPS/EM，多功能M2/M2e/M5/M5e，配套機械臂 ● 試劑GPCR分析，ADME分析，Microgenomics，激酶、磷酸酶、磷酸二酯酶分析，離子通道分析，轉(zhuǎn)錄因子分析，污染測試分析 ● 軟件和認證SoftMax Pro Validation Package和SpectraTest Hardware ValidationPackage(IQ/OQ/PQ認證)
公司網(wǎng)址：http://www.moleculardevices.com.cn/
美國分子儀器公司(Molecular Devices) 上海代表處 電話: 021-6887 8820 ;傳真: 021-3372 1088
地址：上海市徐匯區(qū)宜山路1388號民潤大廈8樓
丹納赫是全球科學和技術的創(chuàng)新者，致力于幫助我們的客戶應對復雜的挑戰(zhàn)和改善全球生活品質(zhì)。我們在最前沿和富有吸引力的領域，擁有眾多世界一流的品牌。全球超過66000名員工的團隊，運用強大的管理流程-丹納赫業(yè)務體系DBS引領我們始終處于領先。2013年獲得191億美金的營業(yè)額，位列美國財富200強。在過去的20年中，丹納赫的股價表現(xiàn)優(yōu)異，超過標準普爾指數(shù)將近2800%。全球五大戰(zhàn)略平臺分別是電子測試和測量，環(huán)境質(zhì)量、齒科產(chǎn)品、生命科學和診斷、和工業(yè)技術。
在中國，丹納赫始終保持高速增長，擁有超過6000名員工和16億美金的營業(yè)額。二十二家中國營運公司和超過一百家的分支機構(gòu)，不但為中國客戶提供著全方位的產(chǎn)品和服務，也為卓越人才提供更好的工作機遇和職位發(fā)展平臺。了解更多信息，請訪問公司網(wǎng)站：www.danaher.com.
Molecular Devices, LLC is headquarted in Sunnyvale, California, United States, in the heart of Silicon Valley, manufacture in Shanghai, Sunnyvale and Salzburg, and has offices around the world including U.S., French, U.K. Germany, China, Korea, Japan, Brazil, Canada, Austria, Singapore and other 14 regions in total 11 countries. There are nearly 600 staff all over the world with $200~250Million revenue;
Our product line includes: microplate reader series, liquid handling systems, electrophysiological detection systems, neural cell biology instrumentation and software, high content cell imaging systems, bio-chip scanner and software, clone selection system, Threshold System and screening reagents. And microplate reader series covers measurement mode for the light absorption, fluorescence intensity , chemiluminescence, fluorescence polarization, time polarizing fluorescence and the detection methods for end point detection, spectrum scan, fast and slow dynamics.
Molecular Devices is a Danaher company under the Life Science & Diagnostics platform within the five strategic segments.
Danaher is a global science and technology innovator committed to helping our customers solve complex challenges and improve quality of life around the world. Our family of world class brands have unparalleled leadership positions in some of the most demanding and attractive industries. Our team of 66,000 associates around the globe is united by the Danaher Business System which serves as our ultimate competitive advantage. In 2013, we generated $19.1 billion in revenue, earning a spot on the Fortune 200 list. During the past 20 years, our stock has outperformed the S&P 500 Index by nearly 2,800 percent. Danaher five strategic segments are: Test & Measurement, Environmental, Dental, Life Science & Diagnostics, and Industrial Technologies.
With over 6000 associates and $1.6 billion of revenue in China, Danaher continuously achieve high growth in the market. Through 22 China operation companies and more than 100 subsidiaries, Danaher not only provides comprehensive products and services to China client, but also better career opportunities and development platform for talents. For more information please visit our website at www.danaher.com.
